ADJUVANS

European patent · EP3193923 · In force

Register entry

Publication number
EP3193923
Application number
EP15751144
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 24, 2015
Published
Jul 26, 2017
Granted
Sep 18, 2019
Protection ends at the latest
Jul 23, 2035
Next annual fee due
Jul 31, 2027
IPC classes
A61K 39/39 (2006.01)
C07H 13/06 (2006.01)
C07H 11/00 (2006.01)
Priority
NL 2013257 24.07.2014
PCT application
PCT/NL2015/050544 24.07.2015
PCT publication
WO2016/013938 28.01.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  4. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  5. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  6. Sep 18, 2019

    Granted

    Published in Swissreg on 18.09.2019

Parties

Holder

Litevax B.V.

Akkersestraat 50, 4061 BJ Ophemert, NL

Inventor

VAN DEN BOSCH, Johannes F.

NL-5831 CH Boxmeer, NL

HILGERS, Lucas A. Th.

NL-4061 BJ Ophemert, NL

PLATENBURG, Peter Paul L. I.

NL-3945 BL Cothen, NL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.